Last reviewed · How we verify
NCT04166370
Bangladesh MSNP: Social Protection Mixed Methods Study
NA trial testing Control in Stunting. Withdrawn.
28 June 2020
Quick facts
| Lead sponsor | FHI 360 |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Start date | 26 July 2018 |
| Primary completion | 28 June 2020 |
| Estimated completion | 28 June 2020 |
| Sites | 1 location across Bangladesh |
Drugs / interventions tested
- Control
- Strengthened (Services and SBCC)
- Strengthened (Services and SBCC) + CCT
Conditions studied
- Stunting — all drugs for Stunting →
- Undernutrition — all drugs for Undernutrition →
Sponsor
FHI 360 — full company profile →
Who can join
18 and older, female only, with Stunting or Undernutrition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Despite progress in reducing high levels of undernutrition in Bangladesh, gaps in progress persist. They are particularly acute between rural and urban areas, and between the lowest wealth quintile and highest. According to the 2016 Bangladesh DHS report, 38% of rural children under five were stunted compared to 31% of urban children. Forty-nine percent of children in the lowest wealth quintile were stunted compared to 19% in the highest. To address these discrepancies and lower the overall level of stunting, research is being conducted to assist the government of Bangladesh (GoB) in determining the most effective ways to reduce levels of stunting. The primary objective of this research is to compare the effectiveness of two multisectoral nutrition intervention packages--one with and without a conditional cash transfer (CCT) component--to the current standard of practice. A cluster-randomized controlled trial using mixed methods will be used to evaluate effectiveness. The two intervention arms are as follows; * Strengthened: Referrals to health services, strengthened health services, and enhanced social and behavior change communication (SBCC) * Strengthened + CCT: Referrals to health services, strengthened health services, enhanced SBCC and cash transfers conditional on a mother attending antenatal care (ANC) and monthly nutrition education SBCC group sessions. The study's primary outcome is the percentage of children 6-23 months old receiving a minimum acceptable diet (MAD), as a proximate determinant for stunting. MAD is defined as the proportion of children 6-23 months old who receive both the minimum feeding frequency and minimum dietary diversity for their age group and breastfeeding status. It will be assessed based on the mother/caregiver report. Secondary outcomes include assessing the knowledge, attitudes, and practices around breastfeeding, complementary feeding, water sanitation and hygiene, health services and gender norms. Quantitative surveys, in depth interviews, focus group discussions, and detailed program monitoring data will be used to assess intervention strengths, weakness, and cost effectiveness.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Community-level interventions for improving access to food in low- and middle-income countries.
Durao S, Visser ME, Ramokolo V, Oliveira JM, et al · · 2020 · cited 33× · PMID 32722849 · DOI 10.1002/14651858.cd011504.pub2 -
Community-level interventions for improving access to food in low- and middle-income countries.
Durao S, Visser ME, Ramokolo V, Oliveira JM, et al · · 2020 · cited 23× · PMID 32761615 · DOI 10.1002/14651858.cd011504.pub3
Verify or expand the search:
- PubMed search for NCT04166370
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Control
Trials testing the same drug.
- NCT06064604 — Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke · NA · not yet recruiting
- NCT04039386 — Psychosocial Interventions for Young Adults With Hip Pain · NA · not yet recruiting
- NCT07042373 — Effects of Tobacco Abuse Liability-dependent Taxes in the ETM · NA · not yet recruiting
- NCT07512999 — The Effect of Using Nature Sounds and Virtual Reality During the Non-Stress Test · NA · not yet recruiting
- NCT07531563 — Protein Supplementation for Radiation- Induced Oral Mucositis in Head and Neck Cancer Patients Receiving Radiotherapy · NA · not yet recruiting
Other recruiting trials for Stunting
Currently open trials in the same condition.
- NCT07207434 — Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan · Phase 2 · recruiting
- NCT07037498 — Effect of Moringa Royal Jelly on the Nutritional Status and Cognitive Level of Adolescent Girls · NA · active not recruiting
- NCT06362837 — Evaluation of REACTS-IN, an Intervention to Improve Nutrition, Hygiene, and Sexual and Reproductive Health Services · NA · recruiting
- NCT05793294 — Child Health, Nutrition and Microbiome Development · active not recruiting
- NCT06018636 — Impact of Diet and Nutrition on Growth and Development in Young Children · recruiting
Other FHI 360 trials
Trials by the same sponsor.
- NCT05233956 — Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya · NA · active not recruiting
- NCT05937698 — The CATALYST Study · terminated
- NCT05889533 — Eswatini Ring Study: Increasing PrEP Options for Women · terminated
- NCT05016895 — REACH2: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d'Ivoire · NA · completed
- NCT04617626 — Resiliency Through Azithromycin for Children (REACH), Côte d'Ivoire · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04166370 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by FHI 360
- Last refreshed: 5 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04166370.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing